Eckenstein, K.; Cengiz, B.; Chang, M.E.K.; Cartier, J.M.; Flory, M.R.; Thomas, G.V.
Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma. Metabolites 2025, 15, 393.
https://doi.org/10.3390/metabo15060393
AMA Style
Eckenstein K, Cengiz B, Chang MEK, Cartier JM, Flory MR, Thomas GV.
Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma. Metabolites. 2025; 15(6):393.
https://doi.org/10.3390/metabo15060393
Chicago/Turabian Style
Eckenstein, Kazumi, Beyza Cengiz, Matthew E. K. Chang, Jessie May Cartier, Mark R. Flory, and George V. Thomas.
2025. "Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma" Metabolites 15, no. 6: 393.
https://doi.org/10.3390/metabo15060393
APA Style
Eckenstein, K., Cengiz, B., Chang, M. E. K., Cartier, J. M., Flory, M. R., & Thomas, G. V.
(2025). Mitochondrial Translation Inhibition Uncovers a Critical Metabolic–Epigenetic Interface in Renal Cell Carcinoma. Metabolites, 15(6), 393.
https://doi.org/10.3390/metabo15060393